Hydroxychloroquine for early treatment of COVID-19: Absence of evidence is different from evidence of absence
Lancet Reg Health Am
.
2022 Aug:12:100314.
doi: 10.1016/j.lana.2022.100314.
Epub 2022 Jul 10.
Author
Leonardo Furlan
1
Affiliation
1
School of Medicine, University of São Paulo, 455 - Cerqueira César, CEP: 01246903, São Paulo, SP, Brazil.
PMID:
35844777
PMCID:
PMC9271171
DOI:
10.1016/j.lana.2022.100314
No abstract available